Haemonetics Corp. diskutieren
Haemonetics Corp.
WKN: 881782 / Symbol: HAE / Name: Haemonetics / Aktie / Ausrüstung & Versorgung / Mid Cap /
67,00 €
1,53 %
Haemonetics (NYSE:HAE) was given a new $80.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) was given a new $70.00 price target by Mizuho. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) had its price target lowered by Barrington Research from $94.00 to $89.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $80.00 price target on the stock, up from $72.00.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) had its "buy" rating reaffirmed by BTIG Research. They now have a $84.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) had its "buy" rating reaffirmed by BTIG Research. They now have a $84.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (HAE) had its price target raised by Mizuho from $85.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in M&T Bank Corp. diskutieren